DECR1 and prostate cancer: Furthermore, knocking down 2,4-dienoyl–CoA reductase (DECR1), an enzyme involved in fatty acid oxidation, causes cellular accumulation of PUFAs and enhances mitochondrial oxidative stress and lipid peroxidation in human prostate cancer (53).